# Andreas von Deimling

Source: https://onco.cc/people/andreas-von-deimling/  
OnCo record `andreas-von-deimling` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Co-created the DNA methylation classifier that changed how brain tumours are diagnosed worldwide.

## Summary

Andreas von Deimling is Head of Neuropathology at Heidelberg University Hospital and the German Cancer Research Center (DKFZ). His specialisms are neuropathology, brain tumour classification and DNA methylation profiling, with a research interest in IDH1 and IDH2 in glioma and glioblastoma. With Stefan Pfister and David Capper he developed the Heidelberg DNA methylation-based classifier for central nervous system tumours, published in Nature and now embedded in the WHO classification. The classifier changed how brain tumours are diagnosed worldwide, and his publications are listed on PubMed.

## Fields

- Kind: Person
- Last checked: 2026-09-08
- Role: Head of Neuropathology, Heidelberg University Hospital and DKFZ
- Specialisms: Neuropathology; Brain tumour classification; DNA methylation profiling

## Sources

- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=von%20Deimling%20A%5BAuthor%5D%20methylation%20classifier

## Connected records

- cancers: [Glioma & glioblastoma](https://onco.cc/cancers/glioblastoma/)
- technologies: [DNA methylation profiling](https://onco.cc/technologies/methylation-profiling/)
- targets: [IDH1 / IDH2](https://onco.cc/targets/idh/)
- institutions: [German Cancer Research Center (DKFZ)](https://onco.cc/institutions/dkfz/), [Heidelberg University Hospital / NCT / DKFZ](https://onco.cc/institutions/heidelberg-nct/)

---
JSON: https://onco.cc/api/v1/entities/andreas-von-deimling.json